Loading...
XSHG
600976
Market cap800mUSD
Dec 05, Last price  
36.89CNY
1D
-0.24%
1Q
-11.32%
Jan 2017
15.53%
IPO
373.25%
Name

Jianmin Pharmaceutical Group Co Ltd

Chart & Performance

D1W1MN
XSHG:600976 chart
P/E
15.62
P/S
1.61
EPS
2.36
Div Yield, %
3.25%
Shrs. gr., 5y
-0.16%
Rev. gr., 5y
9.38%
Revenues
3.50b
-16.81%
911,088,4401,291,749,9091,036,121,096835,351,7661,533,865,7191,571,985,4791,412,848,8841,539,745,1691,992,391,1181,753,488,3892,281,220,6002,363,653,0712,711,502,8222,161,476,6372,238,937,1232,455,996,2983,278,183,6403,640,800,4774,213,154,5723,504,986,068
Net income
362m
-30.54%
20,020,96711,487,1548,326,46615,778,43648,857,82771,686,22278,251,42682,450,68995,903,530115,970,44285,500,17064,655,61190,777,56081,217,73591,490,271147,788,378305,258,203408,080,739521,457,677362,178,656
CFO
234m
-12.71%
056,175,2020110,107,98366,693,463150,079,034098,173,81645,358,292103,228,93448,449,871113,840,27135,197,18263,598,25374,449,432125,538,929259,183,455215,865,263268,389,661234,265,079
Dividend
Apr 26, 20241.2 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells Chinese medicines in China. It offers pediatric drugs under the Jianmin and Longmu brands. The company also provides OTC, medical, and health products, as well as consultation service. Jianmin Pharmaceutical Group Co.,Ltd. is headquartered in Wuhan, China.
IPO date
Apr 19, 2004
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT